Kiora Pharmaceuticals, Inc.
KPRXNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $14.15M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.77$2.91
- Volume (live)
- -
- Avg. volume (3M)
- 14.97K
Kiora Pharmaceuticals (KPRX) Stock Price & Financial Analysis
Kiora Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.24 - $2.37 |
|---|---|
| 52-Week High | $2.91 |
| 52-Week Low | $1.77 |
| Open | $2.32 |
| Volume (last close) | 24.42K |
| Average Volume (3M) | 14.97K |
| 50-Day MA | $2.58 |
|---|---|
| 200-Day MA | $2.41 |
| 1-Year Change | −8.66% |
| Market Cap | 14.15M |
|---|---|
| Shares Outstanding | 6.18M |
| Price to Book (P/B) | 0.84 |
| EV/EBITDA | -0.62 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Kiora Pharmaceuticals at a Glance
As of the Oct 23, 2026 close, Kiora Pharmaceuticals (KPRX) has a market capitalization of $14.15M. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $7.08M in cash and securities against $333.02K of debt, a net cash position of $6.74M.
Kiora Pharmaceuticals does not currently pay a dividend.
The share price is down 8.7% over the past year. At $2.29 (the Oct 23, 2026 close) it sits within its 52-week range of $1.76 to $2.91, below its 200-day moving average of $2.41.
Frequently Asked Questions About Kiora Pharmaceuticals
What is the current stock price for KPRX?
As of the Oct 23, 2026 close, KPRX stock trades at $2.29. The 52-week range is $1.77–$2.91, with a day range of $2.24–$2.37.
What is the P/E ratio for KPRX?
The P/E ratio (Price-to-Earnings) for KPRX is shown in the Key Statistics section. This valuation metric helps compare Kiora Pharmaceuticals, Inc. to industry peers.
Does KPRX pay dividends?
Kiora Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for KPRX?
Analyst ratings and recommendations for KPRX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of KPRX?
As of the Oct 23, 2026 close, Kiora Pharmaceuticals's market capitalization is $14.1M, classifying it as a micro-cap company. Kiora Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.